Latest Earnings Results: Q2 '26
Estimated EPS
-$0.34
Reported EPS
-$0.36
Surprise
-5.11%
Estimated Rev
$6.68M
Reported Rev
$3.42M
Surprise
-48.75%
Profound Medical Corp. reported Q2 2026 revenue of $2,483, up from $2,211 in Q2 2025, while the net loss attributed to shareholders decreased to $9,540 from $15,695 in the prior year.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.31 | -- | -- | N/A |
Q2 '26 | -$0.34 | -$0.36 | -5.11% | MISSED |
Q1 '26 | -$0.34 | -$0.27 | 22.45% | BEAT |
Q4 '25 | -$0.37 | -$0.37 | 1.38% | BEAT |
Q3 '25 | -$0.52 | -$0.35 | 31.59% | BEAT |